Abeona Therapeutics (ABEO)

[micasey123]

CC tomorrow .

Access Pharmaceuticals Announces Conference Call to Discuss Recent Acquisition NewsLast update: 2/21/2007 2:48:00 PMDALLAS, Feb 21, 2007 /PRNewswire-FirstCall via COMTEX/ -- Access Pharmaceuticals, Inc. (ACCP) announced today that it will conduct a conference call to discuss its proposed acquisition of Somanta Pharmaceuticals with the investment community. The call will take place on Thursday, February 22, 2007, after the financial markets close at 4:00 pm EST. Mr. Stephen R. Seiler, President and CEO of Access and Dr. Agamemnon Epenetos, CEO of Somanta will co-host the call. Interested parties may participate in the call by dialing [phone]; international callers dial [phone] about 5-10 minutes prior to 4:00 pm EST. The conference call will also be available on replay starting at 7:00 pm EST on February 22, 2007, and ending on March 22, 2007. For the replay, please dial [phone] (replay account # 294, replay conference # 232644). The access number for the replay for international callers is [phone] (replay account # 294, replay conference # 232644). About Access Pharmaceuticals, Inc. Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company focused on developing and commercializing propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase II clinical testing of patients with ovarian cancer and MuGard(TM) for the management of patients with mucositis for which marketing allowance has been granted by the FDA. The Company also has other advanced drug delivery technologies including Cobalamin(TM)-mediated targeted delivery and oral drug delivery. For additional information on Access Pharmaceuticals